Central Trust Company’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9K Sell
300
-2
-0.7% -$86 ﹤0.01% 1104
2025
Q4
$13.2K Buy
302
+2
+0.7% +$83 ﹤0.01% 1074
2025
Q3
$12.4K Sell
300
-100
-25% -$4.02K ﹤0.01% 1072
2025
Q2
$17.6K Sell
400
-50
-11% -$2K ﹤0.01% 1011
2025
Q1
$16.6K Sell
450
-100
-18% -$3.56K ﹤0.01% 1004
2024
Q4
$18.3K Sell
550
-350
-39% -$11.4K ﹤0.01% 986
2024
Q3
$23.4K Hold
900
﹤0.01% 918
2024
Q2
$20.2K Sell
900
-338
-27% -$7.5K ﹤0.01% 931
2024
Q1
$29.4K Sell
1,238
-460
-27% -$10.2K ﹤0.01% 906
2023
Q4
$40.7K Sell
1,698
-62
-4% -$1.35K ﹤0.01% 830
2023
Q3
$38.5K Hold
1,760
﹤0.01% 820
2023
Q2
$33.6K Buy
+1,760
New +$33.9K ﹤0.01% 849
2021
Q3
Sell
-690
Closed -$13K 1259
2021
Q2
$13K Sell
690
-4,120
-86% -$96.1K ﹤0.01% 973
2021
Q1
$109K Buy
4,810
+3,825
+388% +$86.4K ﹤0.01% 589
2020
Q4
$20K Buy
+985
New +$20.6K ﹤0.01% 801
2019
Q2
Sell
-4,180
Closed -$99K 1143
2019
Q1
$99K Buy
+4,180
New +$95.3K 0.01% 536

Other funds holding EXEL

Central Trust Company's EXEL Position: Q1 2026 in Review

Central Trust Company reduced its Exelixis (EXEL) stake by 0.66% in Q1 2026, selling an estimated $86 and leaving 300 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Central Trust Company first reported a position in EXEL in Q1 2019 and has held it in 16 quarters since. The position peaked at $109K in Q1 2021. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Central Trust Company held 300 shares of Exelixis worth $12.9K as of Q1 2026.
  • Central Trust Company sold 2 Exelixis shares in Q1 2026, an estimated $86.
  • Exelixis made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #1104 holding.
  • Central Trust Company first reported a position in Exelixis in Q1 2019 and has held it in 16 quarters since.
  • Central Trust Company's Exelixis position peaked at $109K in Q1 2021.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.